Cargando…
Targeting DNA Methylation Depletes Uterine Leiomyoma Stem Cell–enriched Population by Stimulating Their Differentiation
Uterine leiomyoma (LM) is the most common tumor in women and can cause severe morbidity. Leiomyoma growth requires the maintenance and proliferation of a stem cell population. Dysregulated deoxyribonucleic acid (DNA) methylation has been reported in LM, but its role in LM stem cell regulation remain...
Autores principales: | Liu, Shimeng, Yin, Ping, Xu, Jingting, Dotts, Ariel J, Kujawa, Stacy A, Coon V, John S, Zhao, Hong, Shilatifard, Ali, Dai, Yang, Bulun, Serdar E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7497820/ https://www.ncbi.nlm.nih.gov/pubmed/32812024 http://dx.doi.org/10.1210/endocr/bqaa143 |
Ejemplares similares
-
Progesterone receptor-DNA methylation crosstalk regulates depletion of uterine leiomyoma stem cells: A potential therapeutic target
por: Liu, Shimeng, et al.
Publicado: (2021) -
Progesterone receptor integrates the effects of mutated MED12 and altered DNA methylation to stimulate RANKL expression and stem cell proliferation in uterine leiomyoma
por: Liu, Shimeng, et al.
Publicado: (2018) -
Tryptophan 2,3-Dioxygenase-2 in Uterine Leiomyoma: Dysregulation by MED12 Mutation Status
por: Hutchinson, Anne P., et al.
Publicado: (2022) -
MED12 mutation activates the tryptophan/kynurenine/AHR pathway to promote growth of uterine leiomyomas
por: Zuberi, Azna, et al.
Publicado: (2023) -
THU625 Med12 Mutation Activates Tryptophan-Kynurenine-ahr Pathway To Promote Growth Of Uterine Leiomyoma
por: Zuberi, Azna, et al.
Publicado: (2023)